tranylcypromine has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emory, H; Mizrahi, N | 2 |
2 other study(ies) available for tranylcypromine and Autoimmune Diabetes
| Article | Year |
|---|---|
Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
Topics: Adult; Depressive Disorder; Diabetes Mellitus, Type 1; Female; Humans; Magnetic Resonance Imaging; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Selegiline; Tranylcypromine | 2016 |
Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes.
Topics: Biomarkers; Blood Glucose; Brain; Brain Mapping; Brain Waves; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Electroencephalography; Humans; Hypoglycemic Agents; Insulin Glargine; Insulin Lispro; Insulin Resistance; Insulins; Male; Monoamine Oxidase Inhibitors; Predictive Value of Tests; Tranylcypromine; Treatment Outcome; Young Adult | 2017 |